Mass screening for neuroblastoma in Japan: Lessons learned and future directions
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 37 (7) , 949-954
- https://doi.org/10.1053/jpsu.2002.33814
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in JapanCancer, 2001
- Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplificationJournal of Pediatric Surgery, 2000
- Mass screening for neuroblastoma at 6 months of age: Difficult to justifyJournal of Pediatric Surgery, 1998
- Natural history of neuroblastoma found by mass screeningThe Lancet, 1997
- Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in JapanJournal of Pediatric Surgery, 1996
- Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older childrenThe Journal of Pediatrics, 1991
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984
- Neuroblastoma. Mass screening for early detection and its prognosisCancer, 1984
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971